LENDINGTREE, INC.

Recommendation history

• Q1 2022HoldHold: LendingTree’s diversified marketplace is adapting well, but the call confirmed a weaker 2022 setup. Consumer remains strong with expected 45%–55% revenue growth, while Home is expected to decline 15%–25% and Insurance growth was reduced to 5%–10%; insurance margin recovery and lower mortgage acquisition costs remain unproven. TreeQual and improved purchase-mortgage conversion offer meaningful upside, but their 2022 financial impact is still limited.
• Q4 2021HoldHold: LendingTree is navigating a difficult mortgage and insurance cycle better than feared, but the call did not establish a clean earnings inflection. Mortgage revenue was roughly flat year over year despite industry refinance volume down about 50%, supported by revenue per lead up more than 50%; however, Medicare missed internal expectations, credit-card margins remain pressured, and TreeQual is unlikely to materially contribute financially until beyond 2022.
• Q3 2021HoldHold: LendingTree showed strong underlying demand in Home and Consumer—Home VMD rose 65% year over year and mortgage revenue per lead increased 78%—but insurance deterioration is worsening and management expects Q4 EBITDA to fall from just over $40 million in Q3 to roughly $20 million. The recovery case depends on insurance carriers receiving rate increases, consumer monetization initiatives, and operating leverage that management has not yet quantified.
• Q2 2021HoldHold: LendingTree showed a genuine recovery, with personal-loan inquiries up 40% sequentially and revenue up 70%, while management said mortgage share and lender capacity are improving. However, consumer contribution margin remains only about half of 2019 levels, card unit economics remain below pre-pandemic levels, and the $8 million-$9 million Medicare investment is expected to be roughly EBITDA breakeven in 2021, leaving the margin recovery and valuation dependent on execution.
• Q1 2021HoldHold. Q1 execution was strong, led by record Home revenue and Insurance exiting March at over 30% growth, but the recovery is not yet broad: credit-card revenue was $17.6 million versus $51 million a year ago and only 43% of pre-COVID revenue capacity, with VMM below 10%. Q2 guidance implies modest Home revenue decline but better margins, continued Insurance momentum, and only a cautious Consumer recovery; the refi peak and uncertain borrower demand make this a wait-for-proof story rather than a clean buy.
• Q4 2020HoldHold: LendingTree exited 2020 with strong Home momentum—mortgage revenue per lead rose 35% year over year, volume increased 15%, and segment growth of 51% continued into Q1. However, Q1 profitability is pressured by mortgage mix and rebuilding Credit Card at roughly breakeven, while My LendingTree monetization and competitive differentiation remain unproven.
• Q3 2020HoldHold: LendingTree showed durable execution through COVID, with more than $50 million of adjusted EBITDA generated over the prior two quarters, core mortgage revenue up 14% and refinance growth above 30%; insurance also benefited from broad-based carrier spending, with revenue per lead up more than 10% sequentially. However, the recovery remains early: credit-card revenue should grow substantially from a depressed base in Q4 but is expected to weigh on contribution, while My LendingTree monetization remains largely unproven and insurance integration is still de minimis.